APA
Preisler H. D., Raza A., Barcos M., Azarnia N., Larson R., Walker I., Browman M., Grunwald H., D'Arrigo P. & Doeblin T. (19870305). High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Preisler H D, Raza A, Barcos M, Azarnia N, Larson R, Walker I, Browman M, Grunwald H, D'Arrigo P and Doeblin T. 19870305. High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Preisler H. D., Raza A., Barcos M., Azarnia N., Larson R., Walker I., Browman M., Grunwald H., D'Arrigo P. and Doeblin T. (19870305). High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Preisler H D, Raza A, Barcos M, Azarnia N, Larson R, Walker I, Browman M, Grunwald H, D'Arrigo P and Doeblin T. High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19870305.